相似文献
1
HIV-1 and HCV infections among antibody-negative blood donors.
N Engl J Med. 2004 Nov 18;351(21):2232-5; author reply 2232-5.
2
Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
N Engl J Med. 2004 Aug 19;351(8):760-8. doi: 10.1056/NEJMoa040085.
3
Chiron's procleix HIV-1/HCV assay receives FDA approval.
Expert Rev Mol Diagn. 2002 Mar;2(2):94.
4
HIV-1 and HCV infections among antibody-negative blood donors.
N Engl J Med. 2004 Nov 18;351(21):2232-5; author reply 2232-5. doi: 10.1056/NEJM200411183512117.
5
Detection of hepatitis C virus and human immunodeficiency virus-1 antibody-negative donations: Canadian Blood Services' experience with nucleic acid testing.
Vox Sang. 2006 Apr;90(3):204. doi: 10.1111/j.1423-0410.2006.00741.x.
6
NAT yield for human immunodeficiency and hepatitis C viruses in Brazilian blood donors: preliminary results.
Transfus Med. 2015 Apr;25(2):125-7. doi: 10.1111/tme.12180. Epub 2015 Feb 26.
7
Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Vox Sang. 2007 Jan;92(1):8-14. doi: 10.1111/j.1423-0410.2006.00857.x.
8
Canada introduces hepatitis C test.
AIDS Patient Care STDS. 1999 Apr;13(4):250.
9
HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.
J Clin Virol. 2007 Aug;39(4):282-7. doi: 10.1016/j.jcv.2007.05.001. Epub 2007 Jul 5.
10
Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
Vox Sang. 2004 Apr;86(3):198. doi: 10.1111/j.0042-9007.2004.00414.x.
Zotero 插件